Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 5/20 | 0.61 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.60 |
| ▸ | CTSB | P07858 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.53 |
| ▸ | F13A1 | P00488 | 1/20 | 0.53 |
| ▸ | TGM2 | P21980 | 1/20 | 0.53 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.52 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.52 |
| ▸ | CXCL8 | P10145 | 4/20 | 0.50 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31187485 | 0.89 | MEN1 (0.66) | DPP3CAPN1CTSBMEN1KMT2A | |
| SCHEMBL32681271 | 0.88 | DPP3 (0.66) | DPP3CAPN1CTSBKISS1RF13A1 | |
| SCHEMBL30690108 | 0.86 | CAPN1 (0.59) | DPP3CAPN1CTSBMEN1KMT2A | |
| SCHEMBL30690062 | 0.86 | CAPN1 (0.59) | DPP3CAPN1CTSBMEN1KMT2A | |
| SCHEMBL30690107 | 0.86 | CAPN1 (0.59) | DPP3CAPN1CTSBMEN1KMT2A | |
| SCHEMBL30690095 | 0.86 | CAPN1 (0.54) | DPP3CAPN1CTSBMEN1KMT2A | |
| SCHEMBL32681285 | 0.85 | CAPN1 (0.63) | DPP3CAPN1CTSBKISS1RF13A1 | |
| SCHEMBL30209475 | 0.85 | DPP3 (0.55) | DPP3CAPN1CTSBMEN1KMT2A | |
| SCHEMBL30690070 | 0.84 | CAPN1 (0.57) | DPP3CAPN1CTSBNTSR2NTSR1 | |
| SCHEMBL30690087 | 0.84 | CAPN1 (0.57) | DPP3CAPN1CTSBNTSR2NTSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111802649-B | Preparation method and application of LGG fermentation product containing immunoregulatory peptide functional component | 河北弗蒙特生物科技有限公司 | 2023-06-06 | — | — | CN | claimed |
| CN-111802649-B | Preparation method and application of LGG fermentation product containing immunoregulatory peptide functional component | 河北弗蒙特生物科技有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-111802649-B | Preparation method and application of LGG fermentation product containing immunoregulatory peptide functional component | 河北弗蒙特生物科技有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-112592396-B | Bioactive peptide VDPFSKKDW as well as preparation method and application thereof | 上海交通大学 | 2022-10-21 | — | — | CN | disclosed |
| CN-112574291-B | Bioactive peptide SHRKFSAPRHGLGFLPR and preparation method and application thereof | 上海交通大学 | 2022-10-21 | — | — | CN | disclosed |
| CN-112480234-B | Bioactive peptide AAGGYDVEKNNSRIKLGLK and preparation method and application thereof | 上海交通大学 | 2022-10-04 | — | — | CN | disclosed |
| CN-112480235-B | Bioactive peptide SGSAAWDDSAGGAGGQGLRVTAL, and preparation method and application thereof | 上海交通大学 | 2022-07-15 | — | — | CN | disclosed |
| CN-112500468-B | Bioactive peptide RLAFIAHPKLG, and preparation method and application thereof | 上海交通大学 | 2022-07-15 | — | — | CN | disclosed |
| CN-112480232-B | Bioactive peptide VSLADLQNDEVAFR, and preparation method and application thereof | 上海交通大学 | 2022-07-15 | — | — | CN | disclosed |
| CN-112778410-B | Bioactive peptide SAPRHGSLGFLPRK, and preparation method and application thereof | 浙江辉肽生命健康科技有限公司 | 2022-05-31 | — | — | CN | disclosed |
| CN-112724239-B | Bioactive peptide with amino acid structure NKELDPVQKLFVDKIREYK and application thereof | 浙江辉肽生命健康科技有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-112759634-B | Bioactive peptide with amino acid structure FEYIEENKY, and preparation method and application thereof | 浙江辉肽生命健康科技有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-112481246-B | Bioactive polypeptide FSPANKKLTPKKY, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112480236-B | Bioactive peptide LECVEPNCRSKR, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112500469-B | Bioactive polypeptide AAPAAPAAAPPAE, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112625112-B | Bioactive polypeptide PAAPAQLPKKI, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112625113-B | Bioactive peptide AGYDVEKNNSRIKLGLK, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112592902-B | Bioactive peptide ASEPPVLDVKRPFLC, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112646022-B | Bioactive peptide PKCPKCDKEVYFAERV, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-29 | — | — | CN | disclosed |
| CN-112501140-B | Bioactive polypeptide YFGSGFAAPFFIVRHQLLKK, and preparation method and application thereof | 熊猫乳品集团股份有限公司 | 2022-03-18 | — | — | CN | disclosed |